Kura Oncology, Inc.
KURA
$7.34
$0.050.69%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 32.41% | 9.01% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 27.48% | 6.17% | |||
| Operating Income | 62.50% | -6.17% | |||
| Income Before Tax | 68.39% | -7.02% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 64.68% | -7.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 64.68% | -7.02% | |||
| EBIT | 62.50% | -6.17% | |||
| EBITDA | 62.71% | -6.18% | |||
| EPS Basic | 64.76% | -6.63% | |||
| Normalized Basic EPS | 44.36% | -6.65% | |||
| EPS Diluted | 64.76% | -6.63% | |||
| Normalized Diluted EPS | 44.36% | -6.65% | |||
| Average Basic Shares Outstanding | 0.21% | 0.36% | |||
| Average Diluted Shares Outstanding | 0.21% | 0.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
